Icon unveils plant production technology
Germany's Icon Genetics has published details of its proprietary expression technology, designed to improve the production of biopharmaceuticals and other proteins in genetically-modified plants.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs